Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Insmed (INSM) to Release Quarterly Earnings on Tuesday
08:02am, Sunday, 23'rd Feb 2020
Insmed (NASDAQ:INSM) will be releasing its earnings data before the market opens on Tuesday, February 25th. Analysts expect Insmed to post earnings of ($0.59) per share for the quarter. Persons that w
FY2019 EPS Estimates for Insmed Incorporated (NASDAQ:INSM) Increased by Analyst
06:32am, Sunday, 23'rd Feb 2020
Insmed Incorporated (NASDAQ:INSM) – Investment analysts at Svb Leerink boosted their FY2019 earnings estimates for shares of Insmed in a research note issued to investors on Tuesday, February 18th.
Insmed (NASDAQ:INSM) Raised to "Hold" at Zacks Investment Research
07:50am, Saturday, 22'nd Feb 2020
Zacks Investment Research upgraded shares of Insmed (NASDAQ:INSM) from a sell rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Insmed is a bioph
Is There An Opportunity With Insmed Incorporated's (NASDAQ:INSM) 49% Undervaluation?
01:15pm, Thursday, 20'th Feb 2020
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Insmed Incorporated...
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It’s 49% Undervalued
12:23pm, Thursday, 20'th Feb 2020
Today we will run through one way of estimating the intrinsic value of Insmed Incorporated (NASDAQ:INSM) by taking the...
Insmed to Present at the 9th Annual SVB Leerink Global Healthcare Conference
01:00pm, Wednesday, 19'th Feb 2020
BRIDGEWATER, N.J., Feb. 19, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Short Interest in Insmed Incorporated (NASDAQ:INSM) Drops By 8.6%
01:58am, Monday, 17'th Feb 2020
Insmed Incorporated (NASDAQ:INSM) saw a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 12,940,000 shares, a drop of 8.6% from th
Insmed (INSM) Receives a Buy from Credit Suisse
12:38pm, Thursday, 13'th Feb 2020
In a report released yesterday, Martin Auster from Credit Suisse maintained a Buy rating on Insmed (INSM), with a price target of $49.00. The company's
Insmed (INSM) Receives a Buy from Credit Suisse
12:38pm, Thursday, 13'th Feb 2020
In a report released yesterday, Martin Auster from Credit Suisse maintained a Buy rating on Insmed (INSM – Research Report),
ArTara Therapeutics announces Blaine Davis as CFO TARA;INSM
01:11pm, Tuesday, 11'th Feb 2020
ArTara Therapeutics announces Blaine Davis as CFO TARA INSM
Insmed to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, February 25, 2020
01:00pm, Monday, 10'th Feb 2020
BRIDGEWATER, N.J., Feb. 10, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, t
Insmed (NASDAQ:INSM) Raised to "Hold" at BidaskClub
06:09pm, Saturday, 08'th Feb 2020
BidaskClub upgraded shares of Insmed (NASDAQ:INSM) from a sell rating to a hold rating in a research note released on Wednesday, BidAskClub reports. Several other equities analysts have also recently
Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More
12:48pm, Friday, 07'th Feb 2020
The president’s State of the Union address was wide-ranging, as they tend to be, but those who tuned in heard mention of two hot health policy topics:
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
12:47pm, Thursday, 06'th Feb 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced gr
